CDKN2A and carcinoma: Comprehensive molecular genetic studies of AC have shown various mutations in HPV-positive cases, especially those involving the phosphoinositol-3-kinase pathway (including PIK3CA, PTEN, and AKT1/2), while HPV-negative carcinomas often show TP53 mutation and loss of CDKN2A [26–31].